ABOUT US PIPELINE INVESTORS CAREERS THE FUTURE OF VACCINES We are pioneering the next generation of cancer immunotherapies and vaccines for infectious diseases CONFERENCE CALL Replay to follow of conference call regarding the contract award for supply of freeze-dried IMVAMUNE to the U.S: Government. » Click for details NEWS & EVENTS NEWS EVENTS September 27, 2017 Bavarian Nordic Secures Contract Award for Supply of Freeze-dried IMVAMUNE Smallpox Vaccine to the U.S. Government September 21, 2017 Bavarian Nordic Provides Update on its Universal RSV Vaccine September 14, 2017 Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic’s Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer View more INVESTOR Stock price 290.00 Last (DKK) -2.00 Change (DKK) More Information FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.

ABOUT US PIPELINE INVESTORS CAREERS EXECUTIVE MANAGEMENT Paul Chaplin President & CEO View more Ole Larsen Executive Vice President, Chief Financial Officer View more Henrik Birk Executive Vice President, Chief Operating Officer View more Tommi Kainu Executive Vice President, Chief Business Officer View more MANAGEMENT Executive Management Board of Directors FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.

ABOUT US PIPELINE INVESTORS CAREERS DIVERSITY IN THE BOARD Target figure for the underrepresented gender in the Board In 2017, within the predefined time horizon, the Board of Directors met its target figure for female board members elected by the general meeting. The target was 15%, corresponding to one member. Considering the Board's current composition as well as the composition of the boards of comparable companies, the Board maintains the target for the period until 2021. In other management levels, the company currently has more than 40% of each gender and as such the share of gender is regarded equal. Over time, should the share for either gender drop below 40%, the company will prepare a policy to increase the share of the underrepresented gender. CORPORATE GOVERNANCE Board Composition and Work Board Committees Board Committee Charters Diversity in the Board Remuneration Policy Articles of Association FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.